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Abstract  
Background and Objective: 
Receiving a Mild Cognitive Impairment (MCI) diagnosis and adjusting to this condition 
is challenging, given the uncertain clinical trajectory surrounding progression to 
dementia.  We aimed to explore the influence of illness perceptions and cognitive 
fusion on coping and emotional responses in a sample of people diagnosed with MCI. 
Research Design & Method: A cross-sectional study of 34 participants with MCI (47% 
female and 53% male, mean age 76.4 years) evaluated the relationships between 
cognitive impairment, illness perceptions and cognitive fusion on levels of distress and 
quality of life (QoL). Participants completed standardised measures for cognitive 
assessment, illness perceptions, cognitive fusion, depression, anxiety and QoL. 
Relationships between variables were analysed using correlation, regression and 
conditional process analyses.  
Results: At the group level, illness perceptions were found to be a stronger predictor 
of depression and QoL in the current sample than objective cognitive impairment. 
Illness perceptions did not directly predict anxiety, rather cognitive fusion significantly 
mediated this relationship. Cognitive fusion also significantly mediated the relationship 
between illness perceptions and depression. Illness perceptions had a significant, 
direct effect on QoL, however there was no significant indirect effect via cognitive 
fusion. Greater fusion with threatening illness perceptions was significantly related to 
increased anxiety and depression. 
Discussion & Implications: Data suggest multiple potential treatment targets in 
helping people diagnosed with MCI to successfully adapt and adjust. Targeting 
appraisals (illness perceptions) using Cognitive Therapy is one potential treatment 
target. In addition, psychological treatments such as Acceptance and Commitment 
Therapy (ACT), which target cognitive fusion, could also warrant further investigation 
in this population, due to the significant indirect paths from illness perceptions to 
distress and QoL, via cognitive fusion.  
Keywords: Mild Cognitive Impairment; Acceptance and Commitment Therapy; Illness 
Perceptions 
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BACKGROUND 
Receiving a Mild Cognitive Impairment (MCI) diagnosis can evoke a broad range of 
emotional responses in people diagnosed with MCI including worry, ambivalence or 
relief (Dean & Wilcock, 2012; Gomersall et al. 2015). MCI is a vague term and makes 
the person confused as to whether they will go on to develop dementia or not (Corner 
and Bond, 2006). Some researchers argue that an MCI diagnosis merely causes 
undue distress for individuals and their caregivers about what may be part of a ‘normal’ 
ageing process (Beard & Neary, 2013; Fang et al., 2017; Whitehouse, 2007). Limited 
research has focused on individual experiences of receiving this diagnosis. 
 
Data from population studies, adopting Petersen’s expanded definition of MCI, indicate 
that approximately 18% of older adults have MCI, with incidence rates of 47.9 (range: 
21.5-71.3) per 1000 person-years (Petersen et al., 2014). People diagnosed with MCI 
are at increased risk of developing dementia, particularly Alzheimer’s disease. 
Research evidence from a large meta-analysis of 41 studies suggests that annual 
progression rates are around 5% to 10% (Mitchell & Shiri-Feshki, 2009), however 
many people diagnosed with MCI experience no further cognitive decline and an 
estimated 16% revert back to ‘normal’ cognitive functioning (Koepsell & Monsell, 2012; 
Sachdev et al., 2013). It should be noted that conversion rates vary widely between 
studies due to differences in study sampling procedures (e.g. memory clinics or 
community based studies) and variation in the operationalization and implementation 
of diagnostic criteria across settings.  
 
A meta-analysis found that anxiety and depression symptoms significantly increase 
risk of progression from MCI to dementia by around 18% and 25% respectively 
(Mourao, Mansur, Malloy‐Diniz, Castro-Costa & Diniz, 2016; Li & Li, 2018). Variations 
in how people adjust psychologically to MCI could be influenced by individual beliefs 
or perceptions about the diagnosis. The Common Sense Model (CSM) of Self-
Regulation (Leventhal, Meyer & Nerenz, 1980; Leventhal, Nerenz & Steele, 1984) 
offers a theoretical framework to explain diversity in individual responses to ill health 
and proposes that ‘illness perceptions’ can have a direct effect on coping behaviour 
and emotional wellbeing. Illness perceptions are appraisals or cognitions that form in 
response to a health-related threat and include: beliefs about how long the illness will 
last, what the consequences will be, how controllable the symptoms are via self-
management or formal treatment and what the possible causes are. The CSM has an 
extensive evidence-base across a range of health conditions including multiple 
4 
 
sclerosis (Dennison, Moss-Morris & Chalder, 2009); chronic pain (Gillanders,  Ferreira,  
Bose, & Esrich (2013); diabetes (Hudson, Bundy, Coventry & Dickens, 2014); and 
cardiovascular conditions (Foxwell, Morley & Frizelle, 2013). A study exploring the 
relationship between illness perceptions and coping behaviour in older adults with MCI 
(n= 63) found significant associations between perceptions of MCI, self-reported 
symptoms and coping (Lin and Heidrich, 2012). A similar study (Lin, Gleason and 
Heidrich, 2012) with well-educated males who had been diagnosed with MCI (n= 30) 
found no significant association between illness perceptions and distress. This study 
was limited by a small homogeneous sample, who received the diagnosis two years 
prior to taking part in the study; thus, potentially not capturing the adjustment period 
following diagnosis. Stevenson (2014) provided some evidence to support the CSM 
with an older adult MCI population (n=19). Perceptions regarding the consequences 
and emotional impact of MCI were associated with increased anxiety symptoms. No 
association was found between perceptions of MCI and quality of life (QoL) in their 
sample. Overall, it was considered that the sample population was generally well-
adjusted.  In addition, the study was considered to have insufficient statistical power 
for the comparisons reported due to low sample size, which may account for the lack 
of association.   
 
There has only been one study to date investigating the effectiveness of a CBT group 
intervention for people diagnosed with MCI (Banningh et al., 2011). Authors compared 
the CBT intervention to a wait list control, on outcome measures of distress, well-being 
and illness appraisals in the form of the Illness Cognition Questionnaire (ICQ; Evers et 
al., 2001). Results showed that participants improved in adaptive appraisals after 
receiving CBT (p = 0.034) compared to the waiting list period. In contrast, distress (p 
= 0.34) and general well-being (p = 0.78) did not improve. This calls into question 
whether the primary mechanism of action of CBT (modification of maladaptive 
appraisals) is in fact strongly linked to outcomes such as distress and quality of life, in 
people diagnosed with MCI. 
 
Acceptance and Commitment Therapy (ACT) (Hayes, Strosahl & Wilson, 1999; 2012) 
is a well-developed framework, describing processes involved in adjustment to health 
conditions. See Graham, Gouick, Krahé & Gillanders, (2016), for a systematic review 
of ACT for long term health conditions. ACT differs from CBT as it focuses on the 
‘function’ rather than the ‘content’ of inner experiences, the ACT model proposes that 
how one relates to internal experiences (e.g. symptoms and their appraisal), 
independent of content or form, is also an important influence on outcomes such as 
5 
 
distress, wellbeing and behaviour. In ACT, this relationship that a person has with their 
thoughts and beliefs is referred to as cognitive fusion or defusion (Gillanders et al., 
2014a). Cognitive defusion is the ability to step back and take a more detached 
perspective on thoughts, seeing them as mental events rather than facts. In contrast, 
cognitive fusion is the tendency for thoughts to be taken literally, and behaviour to be 
overly regulated and influenced by thoughts and beliefs. When ‘fused’, a person acts 
on thoughts as if these were true, and thoughts and beliefs come to dominate 
behaviour and experience over other sources of behavioural regulation (Gillanders et 
al., 2014a).  
 
Studies indicate that cognitive fusion is a significant predictor of psychological distress 
and QoL in a range of health conditions including multiple sclerosis (Ferenbach, 2011), 
chronic pain (McCracken & Vowles, 2014) and cancer (Gillanders et al., 2015). To 
date, there have been no studies investigating the role of cognitive fusion in adjustment 
to MCI. The aim of this study is to investigate the influence of illness perceptions and 
cognitive impairment on levels of distress and QoL in people who were diagnosed with 
MCI approximately three to nine months previously, and to examine whether cognitive 
fusion has a mediating role in relationships between predictor (illness perceptions and 
cognitive impairment) and outcome variables (anxiety, depression and QoL) in people 
diagnosed with MCI.  
 
RESEARCH DESIGN & METHODS 
The study was cross-sectional. Standardised questionnaires were used to measure 
cognitive impairment, appraisals of MCI, cognitive fusion, anxiety, depression and 
QoL. A group of older adults registered with the Patient and Public Advisory Service 
were involved in the design of the study.  
Participants & Procedure 
Power calculations were carried out a-priori, G*power (version 3.1) (Faul, Erdfelder, 
Buchner & Lang, 2009) was used to calculate sample size estimates for correlation 
analysis to detect medium and large effect sizes, with a power of 0.80 and an alpha of 
<0.05. Estimates were n=67 to detect medium effects, Fritz and Mackinnon (2007)  
suggest a sample size of 54 to detect medium-sized indirect effects. 
Participant inclusion criteria included: 1) diagnosis of MCI according to ICD-10 criteria 
(World Health Organisation, 1992) in the last three to nine months; 2) aged sixty years 
or over; 3) fluent in writing and reading English; 4) capacity to consent to taking part. 
Participants were excluded if: 1) resided in a care home; 2) had a significant physical 
or mental health problem (e.g. Parkinson’s disease or schizophrenia); 3) significant 
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sensory impairment, a history of pre-morbid cognitive difficulties, stroke or brain injury, 
and past or present substance misuse; 4) score on the Montreal Cognitive Assessment 
(MoCA; Nasreddine et al. 2005) below the threshold for MCI (<18), suggestive of 
greater cognitive impairment (Freitas, Simões, Alves & Santana, 2013). Participants 
were recruited from XX and XX between March 2017 and February 2018. Participants 
were either identified directly by an XX clinician (Consultant Psychiatrist or Clinical 
Psychologist) involved in the assessment of their memory difficulties, or indirectly 
identified following a case-note review of former memory clinic attendee notes, which 
was carried out by the first author (XX). All participants provided informed consent prior 
to commencement of the study.  
 
Measurements 
1. Demographic questionnaire: including age; gender; marital status; educational 
attainment (years); length of time since diagnosis; onset of cognitive difficulties 
(months); previous or current occupation; and age at retirement, if applicable.  
2. Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) a cognitive 
screening tool assessing several domains of cognition including: memory; language 
skills; visuospatial abilities; and executive functioning. Validation studies suggest that 
the MoCA has high test-retest reliability, good internal consistency (Cronbach’s α = 
0.83) and adequate levels of sensitivity (90%) and specificity (87%) for detecting MCI. 
The maximum MoCA score is 30 and scores between 26 and 18 are clinically indicative 
of MCI. 
3. Geriatric Depression Scale – 5 (Hoyl et al., 1999) a five item, self-report measure 
of depression intended for use with older adults (aged 60+). It has been successfully 
administered to people diagnosed with MCI in previous studies (Lin, Gleason & 
Heidrich, 2012; Stevenson et al. 2014).  A score greater than two out of five is indicative 
of clinical levels of depression (Hoyl et al., 1999). 
4. Geriatric Anxiety Inventory – Short Form (GAI-SF; Byrne & Pachana, 2011) a 
five item, self-report measure of anxiety intended for use with older adults (aged 60+). 
The GAI-SF has been shown to have adequate sensitivity (.75) and internal 
consistency (Cronbach’s α=0.71), and good specificity (.87) in a community-dwelling 
older adult sample (Byrne & Pachana, 2011; Johnco, Knight, Tadic & Wuthrich, 2015). 
A score greater than three out of five is indicative of clinical levels of anxiety.  
5. Illness Perception Questionnaires – Mild Cognitive Impairment (IPQ-MCI; Lin 
et al., 2012) a measure of illness perceptions intended for use with groups of people 
diagnosed with MCI. It is based on the Illness Perception Questionnaire-Revised (IPQ-
R; Moss-Morris et al. 2002), which is a broad-based measure of illness perceptions 
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that can be used across a range of health conditions. The IPQ-MCI has nine subscales: 
identity; cause; consequences; chronic timeline; cyclic; personal control; treatment 
control; coherence; and emotional representation. The cause subscale was omitted in 
this study to reduce respondent burden and because the qualitative interpretation 
required for this item did not fit with the planned analyses. The IPQ-MCI has been 
validated with an MCI population and demonstrates adequate internal consistency 
(Cronbach’s α ranging from .62 to .86) (Lin et al., 2012; Lin & Heidrich, 2012).  
6. Cognitive Fusion Questionnaire (CFQ; Gillanders et al., 2014) a seven item, 
self-report questionnaire measuring cognitive fusion. The CFQ has demonstrated 
adequate internal consistency in an older adult population with chronic pain 
(Cronbach’s α=.74) (Scott, Daly, Yu, & McCracken et al. 2017). The CFQ has not been 
validated with people diagnosed with MCI, however research has demonstrated 
cognitive fusion, as measured by the CFQ, to be a good predictor of anxiety, 
depression and QoL in people with other neurological conditions including multiple 
sclerosis (Gillanders et al. 2014; Valvano et al. 2016) and health conditions such as 
cancer (Gillanders et al. 2015).  
7. Quality of Life in Alzheimer’s Disease (QoL-AD; Logsdon, Gibbons, McCurry 
& Teri, 2002) a 13 item, self-report measure designed specifically to assess QoL in 
people with Alzheimer’s disease. Although the measure was developed for individuals 
with Alzheimer’s disease, rather than MCI, it was selected for use in the current study 
as it incorporates a memory item and has a simple format deemed potentially less 
challenging for individuals with compromised cognition. The QoL-AD has 
demonstrated good concurrent validity and internal reliability (Cronbach’s α=.90) when 
administered to individuals diagnosed with MCI (Tatsumi, Yamamoto, Nakaaki, 
Hadano & Narumoto, 2011).  
Data analysis 
All variables met the assumption of normality, except for GAI-SF, GDS-5 and IPQ-MCI 
subscales: chronic timeline and treatment control. Transformations (square root and 
logarithmic) were conducted and resulted in a marked improvement in normality. There 
were no violations of linearity, homoscedasticity or multi-collinearity. Presence of 
outliers was assessed visually using histograms and statistically using the 
Mahalanobis distance statistic. No significant outliers were identified. Little’s missing 
completely at random (MCAR) test was employed to test if the pattern of missing data 
significantly differed from random. Results indicated that data were not missing at 
random. Non-random missing data were identified for the ‘marriage’ item on the QoL-
AD measure, due to a proportion of participants being single or widowed (n=10). A 
total adjusted QoL-AD score was calculated, omitting the ‘marriage’ item. Bivariate 
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correlations were used to initially explore relationships between all variables. A 
simultaneous forced entry method of regression was selected to analyse the relative 
contribution of the independent predictor variables (threat appraisals and cognitive 
impairment) on anxiety, depression and QoL outcome variables. The bootstrapping 
method of simple mediation analysis (Hayes, 2013) was selected for conditional 
process analyses, as opposed to The Sobel Test (Sobel, 1982) or the Baron and 
Kenny (1986) approach, as it is considered to be a robust method of analysis in 
circumstances where sample size is small (Fritz and MacKinnon, 2007; MacKinnon et 
al. 2002). All statistical analyses were conducted using IBM Statistical Package for 
Social Science (SPSS) version 24 (IBM, 2016). The PROCESS macro for SPSS 
developed by Hayes (2013) was used to conduct simple mediation analyses (model 4) 
using 5000 bootstrap resamples.  
 
Ethics 
Ethical approval was granted from XXX Ethics Committee (reference: 16/SS/0215), 
XX  and XXX (reference: 2016/0320 and L17015) and XXX 
RESULTS 
Ninety participants  were identified as eligible following case-note review and 26 
returned opt-in slips, equating to a return rate of 29%. XX clinicians identified 33 eligible 
participants and 15 returned opt-in slips. A total of 41 participants were recruited and 
only 34 completed the study: one was excluded owing to significant physical health 
problems; two no longer fulfilled the eligibility criteria; three had administrative issues 
and one dropped out. Of the 34 participants included in the study, 47% were female 
and 53% were male, mean age of participants was 76.4 years (range 62-90), 82% of 
participants were retired, 68% were married, 21% widowed, 9% single and 3% 
divorced, years in education across the sample was 14.3 years (SD=3.7). Time since 
onset of cognitive problems varied across the sample: 11.8% reported onset within the 
last year; 38.3% within the last one to three years, 32.3% within the last three to five 
years; and 17.6% reported onset of problems more than five years ago. The mean 
MoCA score was 21.9, all participants were diagnosed with MCI in the past three to 
nine months (M=5.3, SD=2.2). See Table 1 for participants’ demographics.  
- Insert Table 1 here – 
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Distress and quality of life 
Participants scored, on average, slightly higher for anxiety (M=1.8, range 0-5) than 
depression (M=1.1, range 0-5). Across the sample, 21% were experiencing clinical 
levels of anxiety and 12% were experiencing clinical levels of depression. Participant 
scores on the CFQ (M=18.8) were similar to normative samples, however there was 
variability across the sample with scores ranging from 7 to 40, with higher scores 
indicating greater fusion. The mean QoL score (39 out of 52) indicates that overall, the 
sample perceived their QoL to be ‘good’ or ‘excellent’, however individual scores 
ranged more widely from 24 to 50, indicative of greater variability in QoL across the 
sample.  
The number of subjective symptoms reported across the sample was 12, and an 
average of 7 were attributed to MCI. Participants were more likely to endorse cognitive 
(e.g. memory and language deficits) rather than somatic symptoms (e.g. 
cardiovascular or sensory issues). Participants tended to score in the upper range of 
the scale for the appraisal dimensions of ‘timeline’ (M=4.2, SD=0.8) and 
‘consequences’ (M=3.1, SD=0.7) indicating more strongly held beliefs in the sample 
that MCI is a chronic condition with greater negative consequences. Participants 
tended to score in the mid-range on the cyclic subscale (M=2.4, SD=0.9) suggesting 
that overall the sample did not strongly perceived their symptoms to be cyclical in 
nature. Around 51% of the sample reported increased emotionality associated with 
MCI.  
In terms of controllability, the majority of the sample  scored in the upper range of the 
scale suggesting that the overall sample had more positive beliefs about treatments 
for MCI (M=3.0, SD=0.5) and perceived themselves to have greater personal control 
(M=3.1, SD=0.8) over managing their symptoms. Participant understanding of MCI 
was varied, with scores ranging from 1 (limited understanding) to 4.9 (high 
understanding) out of 5.  
 
Correlation analyses 
Pearson’s correlations were conducted to explore the associations between all study 
variables, at the group level. Correlation coefficients for study variables are provided 
in Table 2. The results show a range of moderate correlations in expected directions 
between objective cognitive impairment and the following three variables: chronic 
timeline (r=-.38, p<0.05); personal control (r=.39, p<0.05); and emotional 
representations (r=-.35, p<0.05). Contrary to hypothesis (1), there was no significant 
relationship found between objective cognitive impairment and depression, anxiety or 
QoL. Increased depression was significantly associated with a higher number of self-
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reported MCI symptoms (r=.41, p<0.05) and increased perceptions of MCI as a cyclic 
condition (r=.48, p<0.01). Increased anxiety was significantly associated with more 
negative emotional representations of MCI (r=.52, p<0.01). Reduced QoL was 
significantly associated with a higher number of self-reported MCI symptoms (r=-.50, 
p<0.01) and increased negative appraisals regarding the consequences (r=.53, 
p<0.01) and cyclic nature of MCI (r=-.37, p<0.05).  Greater cognitive fusion was 
significantly associated with increased depression (r=.36, p<0.05) and anxiety (r=.67, 
p<0.01), and reduced QoL (r=-.48, p<0.01), in addition to a higher number of self-
reported MCI symptoms (r=.41, p<0.05), more negative emotional representations of 
MCI ( r=.56, p<0.01) and negative appraisals regarding the consequences (r=.59, 
p<0.01) and cyclic nature of MCI (r=.35, p<0.05) 
 
-Insert Table 2 here- 
 
 
Multivariate analyses: multiple regression 
Although the design of this study was cross sectional, variables were categorized a 
priori as predictor (illness perceptions and cognitive impairment), mediator (cognitive 
fusion) and outcome variables (depression, anxiety and QoL), in order to test 
hypotheses about which psychological factors statistically ‘predict’ these important 
outcomes. Simultaneous forced entry linear regression was conducted to test the 
relative contribution of cognitive impairment and illness perceptions in predicting 
anxiety, depression and QoL. As suggested by Broadbent (2006), seven IPQ-MCI 
subscales were combined to derive an overall ‘threat appraisal’ variable, with higher 
scores denoting more negative appraisals of MCI as threatening.  The overall threat 
appraisal variable was entered into the regression model as one, as opposed to seven 
predictors, in an attempt to conserve power. The composite variable comprised 67 
items and the Cronbach’s alpha indicated adequate internal consistency (α=.86) in the 
current sample. The variable was normally distributed and had a sample mean of 25.9 
(SD=5.66, range=16-42). See Table 3 for results of the regression analyses.  
 
Insert Table 3 here- 
 
Prediction of anxiety, depression and quality of life 
The two predictors accounted for 19% of the variance in depression symptoms (Adj 
R2=.19) and the equation was significant (F(2,31)=4.9,p<0.01). The degree of cognitive 
impairment did not significantly predict depression, however threat appraisals did with 
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a moderate to large effect (β=.48, p<0.05). The two predictors accounted for 31% of 
the variance in QoL (Adj R2=.31,p<0.01) and the equation was significant (F(2,31)=8.3, 
p<0.001). The degree of cognitive impairment did not significantly predict QoL, 
however threat appraisals did with a large effect (β=-.58, p<0.01). The two predictors 
accounted for only 4% of the variance in anxiety symptoms (Adj R2=.04) and the 
equation was non-significant (F(2,31)=1.6, p>0.05). There was no significant individual 
effect of either predictor variable on anxiety.  
 
Conditional process analyses 
Linear regression analysis provided information regarding the relative strength of the 
two predictors on the three psychosocial outcome variables. In order to test more 
complex relationships between the variables, conditional process analysis was 
selected (Hayes, 2013). This method allows for detection of indirect effects between 
the predictor and outcome variables, via a mediating variable. A theoretically informed 
simple mediation model was hypothesized a-priori, which proposed that threat 
appraisals would influence psychosocial variables (depression, anxiety and QoL) 
directly, and indirectly via cognitive fusion. The overall threat appraisals model 
explained 46% of the variance in anxiety. Threat appraisals did not have a significant 
direct effect on anxiety, however they did have a significant indirect effect when 
mediated by cognitive fusion (β=.05, bootstrapped confidence interval (BCI)= .02, .09). 
The overall cognitive impairment model explained 46% of the variance in anxiety. 
Cognitive impairment did not have a direct effect on anxiety and was not indirectly 
mediated by cognitive fusion (β=.02, BCI=-.02, .06). See Figure 1 outlining the two 
overall models predicting anxiety. 
 
-Insert Fig 1 here- 
 
The overall threat appraisals model explained 25% of the variance in depression. 
Threat appraisals did not have a significant direct effect on depression, however they 
did have a significant indirect effect when mediated by cognitive fusion (β=.01, 
BCI=.01, .03). Greater fusion with threat appraisals was associated with increased 
depression. The overall cognitive impairment model explained 27% of the variance in 
depression. Cognitive impairment did not have a significant direct effect on depression 
and was not indirectly mediated by cognitive fusion (β=.014, BCI=-.008, .044). See 
Figure 2 outlining the two overall models predicting depression 
 
-Insert Fig 2 - 
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The overall threat appraisals model explained 39% of the variance in QoL. Threat 
appraisals had a significant direct effect on QoL (β=-.52, BCI=-.900, -.149), but no 
significant indirect effect on QoL via cognitive fusion. The overall cognitive impairment 
model explained 23% of the variance in QoL. Cognitive impairment did not have a 
significant direct effect on QoL and was not indirectly mediated by cognitive fusion (β=-
.20, BCI=-.651, .127). See figure 3 outlines the two overall models predicting QoL. 
 
- Insert Fig 3 – 
 
Discussion 
The purpose of the current study was to investigate the inter-relationships between 
cognitive impairment, illness perceptions, cognitive fusion, distress and QoL, following 
an MCI diagnosis, at the group level. In line with Leventhal’s CSM, results show 
significant associations, in expected directions, between several types of illness 
perceptions and psychosocial adjustment outcomes.  
 
Illness perceptions and adjustment to MCI 
A higher number of self-reported MCI symptoms were associated with increased 
distress and lower QoL. Increased negative beliefs regarding the consequences, cyclic 
nature and emotional impact of MCI were significantly associated with increased 
distress or poorer QoL in this sample. These results are consistent with previous 
research demonstrating associations using the Illness Perception Questionnaire 
(Evans & Norman, 2009; Ferenbach, 2011; Kaptein et al., 2006), and correspond with 
findings from previous studies with people diagnosed with MCI (Stevenson 2014; Lin 
& Heidrich, 2012). Although, the current sample had slightly more positive perceptions 
regarding personal and treatment control compared to Lin et al. (2012) this was not 
significantly associated with reduce distress or improved QoL. This result could be 
related to the structure of the IPQ-MCI. Participants can provide a mid-point, neutral 
answer (‘neither agree nor disagree’). Previous research indicates that participants are 
more likely to select these questionnaire options when they lack knowledge on the 
subject matter (Baka, Figgou & Triga, 2012; Nadler, Weston & Voyles, 2015). Lack of 
knowledge regarding treatments for MCI and ambiguity surrounding etiology and 
prognostic trajectory may therefore have resulted in neutral rather positive or negative 
perceptions for these items (Fang et al., 2017; Gomersall et al., 2015; Karakaya et al., 
2013). Moreover, executive functioning difficulties observed in people diagnosed with 
MCI may result in compromised decision-making capabilities, potentially leading to a 
higher number of mid-point neutral responses. Although the IPQ-MCI was selected for 
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use in the current study due to its specificity for people with MCI, it may increase central 
tendency bias.  
 
There was no significant association in the current sample between severity of memory 
and thinking problems (as measured by the MoCA) and distress. This is contrary to 
previous research in populations with cognitive impairment (Biringer et al. 2005; 
Stillman, Rowe, Arndt & Moser 2012; Spitz, Schönberger & Ponsford, 2013). While 
this was unexpected, other research in populations with neurological conditions 
(Ferenbach, 2011; Spain et al. 2007) has also found no significant impact of disease 
severity on emotional adjustment outcomes. These results might be explained by the 
limited scope of the MoCA, as it is a short cognitive screening tool, rather than a 
detailed measure of participant cognitive functioning.  
 
Our results suggest that appraisals of MCI explain significantly greater variance in 
depression and QoL than objective cognitive impairment. This is consistent with 
research in other health populations (Groarke et al., 2004; Severeijins et al., 2001; 
Spain et al., 2007). The results therefore suggest that participants’ beliefs about MCI 
have greater bearing on mood and life satisfaction following diagnosis than the 
objectively measured severity of their memory and thinking problems. Neither cognitive 
impairment nor threat appraisals significantly predicted anxiety. This finding was 
unexpected, but supported our hypotheses that an additional variable (i.e. cognitive 
fusion) may have a mediating role in determining adjustment outcomes in this 
population.  
 
Despite the objective cognitive assessment not being strongly associated with 
emotional distress outcomes, it was clear that subjective appraisals of cognitive 
complaints (particularly number of cognitive symptoms and the degree to which these 
are subjectively appraised as threatening), were moderately to strongly associated 
with emotional distress and quality of life.  Participants’ appraisal of having little control 
over their condition might also relate to their internal or external Locus of Control 
(Rotter, 1966). This is supported by the finding of a strong negative correlation 
between appraisals of personal control and treatment control. Locus of Control is a 
well-established psychological construct that states that how a person perceives the 
relationship between his or her behaviour and outcomes (such as health status, 
wellbeing, distress and quality of life), will influence a range of other behaviours, 
including help seeking, self-monitoring, goal setting and behavioural regulation. From 
this perspective, it can be hypothesised that participants who experience little sense 
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of control over their MCI may also develop an external locus of control. A person with 
MCI who has an external locus of control may be less likely to engage in self-support 
efforts such as using memory aids, planning, self-regulation of sleep, and structuring 
daily activity. They may also correspondingly seek answers externally, presenting to 
health professionals, depending more heavily on others, seeking pharmacological 
interventions or folk remedies.  
 
Strengths and limitations  
A clear limitation of the study is the low sample size and power. As multiple 
comparisons have been computed with a small sample this also increases the chance 
of type 1 error. Several factors contributed to low recruitment: clinician referral, 
including time pressures during memory clinic appointments; variation in diagnostic 
practices; and lack of ongoing clinical contact with patients in the three to nine months 
post diagnosis. The opt-in recruitment method may have reduced overall participation 
in the study. Although this recruitment method was a condition of ethical approval, it 
may have placed greater demand on the cognitive capabilities of the sample, and may 
have potentially influenced the sample as people who may have held more neutral 
appraisals of MCI may not have felt motivated to take part. A strength of the study is 
that it measured adjustment variables within a specific three to nine month time frame 
post diagnosis. Relationships between appraisals, fusion, distress and QoL are likely 
to be relatively less stable during this first three months post diagnosis. The decision 
to exclude these participants from the current study was made in order to get a more 
stable estimate of the associations between constructs, given the cross sectional and 
self-report methodology used. This is a period of time that requires closer research 
attention in future studies, using longitudinal and experience sampling methodologies 
to track the adjustment process (or disruption to it) over time. Furthermore, the nine-
month boundary and the inclusion of a cognitive screening measure (MoCA) most 
likely minimised the inclusion of participants who had experienced either remittance of 
cognitive problems or further cognitive decline.  
 
Future directions and Clinical implications 
Future research could include analysing individual differences with a multiple-baseline 
single case study design (Blampied, 1999) with a visual and statistical analysis for this 
design (Parker et al., 2012) to understand the individual as opposed to group 
magnitude of illness perception change following ACT intervention. Although the 
current study shows a pattern of relationships at the group level, the work is not yet 
sufficiently developed to provide cut-off scores for identifying individuals whose 
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appraisals or cognitive fusion put them at greater risk of poor adjustment. The findings 
do suggest that future research to identify such cut offs, using the same validated 
measures could be worth pursuing.    
In the clinical context, there are no current published guidelines regarding provision of 
post-diagnostic support for people receiving an MCI diagnosis.  It is likely that memory 
clinic service provision will vary by location and resourcing capacity.  One potential 
avenue for improving post-diagnostic support could be to have a routine review 
appointment after three - six months to assess adjustment/emotional distress and have 
a clinical pathway for referral to psychological therapy.  In the first instance, developing 
guidelines regarding how diagnosis is discussed, providing appropriate literature to 
people diagnosed with MCI would be an important recommendation.  Secondly, 
developing and providing self-help or guided self-help materials for cognitive and/or 
emotional adjustment strategies may reduce the need for a more intensive 
psychological intervention.  
 
Threatening appraisals of MCI significantly predicted depression and QoL in the 
current sample. Cognitive modification treatments, such as CBT, may hold potential to 
improve mood and life satisfaction in people diagnosed with MCI by attempting to 
directly change maladaptive beliefs about the condition. In particular, the current study 
suggests that negative beliefs about the consequences (e.g. ‘MCI will progress to 
dementia’) or cyclic nature (e.g. ‘MCI is very unpredictable’) of MCI should be targeted. 
ACT, which directly targets cognitive fusion, may also offer potential to reduce distress 
in people diagnosed with MCI. ACT may be more fitting for MCI diagnosis, as it would 
aim to change the function rather than the form of threatening illness perceptions. This 
approach may be preferable to direct cognitive-change techniques synonymous with 
Cognitive Therapy, as patient perceptions about their condition could be realistic (e.g. 
‘MCI strongly affects the way others see or treat me’). Rather than attempting to directly 
modify perceptions, ACT would attempt to reduce the regulatory effect perceptions 
were having on patient behaviour (e.g. social avoidance).  
 
Hypotheses described above, related to control appraisals and their impact on 
behaviours intended to deal effectively with MCI could also be tested in future studies. 
Control appraisals could be a treatment target from within a cognitive behavioural 
perspective. Behavioural experiments designed to test out predictions of external 
versus internal control could lead to alterations in such appraisals, and the 
development of greater internal control appraisal and motivation to engage in adaptive 
self-regulation strategies. Alternatively, the findings of this study also suggest that 
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helping people to step back from such appraisals, using ‘defusion’ strategies from 
Acceptance and Commitment Therapy, could be an alternative route to enhancing 
wellbeing and reducing distress for people with MCI. 
 
ACT is fundamentally a behavioural therapy. It teaches people to make room for their 
difficult symptoms, and the thoughts and emotions that accompany these, in order to 
facilitate effective behaviour. Importantly, it teaches people to live in the here and now, 
rather than mentally time travelling to a feared future, or being hooked into past 
memories. In the context of developing ACT for MCI, this could involve teaching 
mindfulness skills to be grounded in the here and now. In addition, defusion skills would 
be used to step back from worries around future progression to dementia, as well as 
step back from ruminations on the impact of MCI on the person’s sense of self. ACT 
for MCI would also spend time connecting with the person’s values, clarifying what 
matters for them now that they have this diagnosis. Time would also be spent 
translating those values into specific actions, and structuring activities to support these 
actions, despite internal or external barriers, would also be a feature. Within these 
‘committed action’ elements of ACT could also be actions that are designed to live 
effectively with, and also reduce the impact of MCI. For example, engaging in planning, 
daily structure, effective communication of wants and needs, use of memory supports 
and technology to assist living with MCI, could all be considered to be actions that 
could help people to live effectively with an MCI diagnosis.  
 
ACT-based interventions for other neurological conditions have shown initial promise 
(e.g. Sheppard, Forsyth, Hickling & Bianchi, 2010; Nordin & Rorsman, 2012; Gillanders 
& Gillanders, 2014b; Graham, Gillanders, Stuart & Gouick, 2015; Whiting, Deane, & 
McLeod, 2017) suggesting that ACT could be successfully adapted for people 
diagnosed with MCI. The availability of well-trained ACT practitioners is a significant 
barrier to making such interventions available in routine practice settings where MCI is 
diagnosed, however. Fortunately, there is good evidence that ACT can be used as an 
overarching framework to support and inform the work of multidisciplinary teams in 
complex healthcare settings (e.g. Gauntlett-Gilbert, 2011). ACT can be used to 
organize the work of teams, and different professionals within a team can be trained 
to deliver elements of ACT work at different levels.  
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Conclusion 
The current study demonstrates additional support for the role of illness perceptions in 
psychosocial adjustment to MCI. Results indicate that cognitive fusion, a construct 
central to ACT, may play an additional role in influencing adjustment outcomes. Our 
findings suggest that illness perceptions could be modified, from within a theoretically 
consistent ACT-model, to improve QoL amongst patients adjusting to MCI.  Findings 
provide an understanding concerning the factors involved in patients’ adjustment to 
MCI and assist with development of assessment and early intervention procedures for 
patients with increased distress or reduced life satisfaction following diagnosis. 
 
Table1: Descriptive statistics for the study sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MoCA: Montreal Cognitive Assessment (Nasreddine et al., 2005); SD= standard 
deviation
Characteristic Mean (SD) 
    
Age 
Education (years) 
MoCA score 
Months since MCI diagnosis 
Age at retirement (n=28) 
 
 
76.4 (7.8) 
14.3 (3.7) 
21.9 (3.1) 
5.3 (2.1) 
62.7 (6.5) 
 
 
 
 
 
 
 
 
 N  
Female 
Male 
Retired 
Marital status 
  Married 
  Divorced 
  Single 
  Widowed 
 
Onset of cognitive problems (years) 
  <1  
  1 - 3 
  3 - 5 
  5+ 
 
16  
18 
28  
 
23 (67.6) 
1 (2.9) 
3 (8.8) 
 7 (20.6) 
 
 
4 (11.8) 
13 (38.8) 
11 (32.3) 
6 (17.6) 
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Table 2: Correlation matrix between independent, mediator and outcome variables 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
1. MoCA 
1 
 
-.10 
 
.24 
 
-.15 
 
.20 
 
.14 
 
-.38* 
 
.09 
 
.39* 
 
-.25 
 
.07 
 
.24 
 
.35* 
2. GDS-5 
 1 
 
.35 
 
-.51** 
 
.36* 
 
.41* 
 
-.23 
 
.32 
 
-.26 
 
.10 
 
.48** 
 
-.18 
 
.13 
3. GAI-SF 
  1 
 
-.32 
 
.67** 
 
.20 
 
-.18 
 
.33 
 
.29 
 
-.38 
 
.21 
 
.03 
 
.52** 
 
4. QoL-AD 
   1 
 
-.48** 
 
-.50** 
 
.31 
 
-.53** 
 
.29 
 
.03 
 
-.37* 
 
.30 
 
-.11 
 
5. CFQ 
    1 
 
.41* 
 
-.29 
 
.59** 
 
.12 
 
-.16 
 
.35* 
 
-.17 
 
.56** 
 
6. Identity 
     1 
 
-.27 
 
.69** 
 
.18 
 
-.18 
 
.50** 
 
-.32 
 
.26 
 
7. Chronic timeline 
      1 -.46** -.03 -.17 -.26 .10 -.27 
8. Consequences 
       1 .13 -.04 .39* -.32 .44** 
9. Personal control 
        
 
1 
 
-.41* 
 
-.03 
 
.15 
 
.29 
 
10. Treatment control 
         
 
1 
 
-.24 
 
-.14 
 
-.24 
 
11. Cyclic 
          
 
1 
 
-.35* 
 
.28 
 
12. Coherence 
           
 
1 
 
-.25 
13. Emotional 
representations 
 
            
 
1 
 
      Note:  *  = Correlation is significant at the 0.05 level (2-tailed) ** = Correlation is significant at the 0.01 level (2-tailed) 
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Table 3: Linear regression for prediction of depression, anxiety and quality of life  
 
 
 
 
 
 
 
 
 
 
 
 
Note:  
* =significant at <0.05 level; **=significant at <0.01 level; ***=significant at <0.001 level  
GAI-SF: Geriatric Anxiety Inventory – Short Form; GDS-5: Geriatric Depression Scale – five item; QoL-AD: Quality of Life in Alzheimer’s Disease. 
 
GAI-SF: Anxiety GDS-5: Depression  QoL-AD: Quality of life 
Variable  B SE B β B SE B β B SE B β 
Cognitive 
impairment 
.03 .03 .21 -.09 .02 -.15 -.19 .31 -.09 
Threat 
appraisal 
.02 .02 .21 .03 .01 .48* -.65 .17 -.58** 
R2 .09 .24 .35 
Adj. R2 .04 .19 .31 
F 1.6 4.9 8.3 
P-value p=.22 p=.01** p=.001*** 
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Figure 1: Conditional process analysis – anxiety models 
 
 
 
 
 
 
 
 BCI 
Path – anxiety  LL UL 
Total effect  
(Threat appraisals to anxiety) 
-.02 .08 
Direct effect 
(Threat appraisals to anxiety) 
-.07 .02 
Total indirect effect 
(Threat appraisals to cognitive fusion to anxiety) 
.02 .09 
Total model R2=.46, p<.0001, 
f2=13.41 
 
Total effect 
(MoCA to anxiety) 
-.04 .14 
Direct effect 
(MoCA to anxiety) 
-.06 .09 
Total Indirect effect 
(MoCA to cognitive fusion to anxiety) 
-.03 .06 
Total model  R2=.46, p<.0001, 
f2=13.08 
Threat appraisals 
Cognitive fusion 
Anxiety 
a =.86**  β =.06** 
Total:  c =.03 
Direct: c’ =.02 
MoCA 
Cognitive fusion 
Anxiety 
a =.65  β =.05** 
Total:  c =.05 
Direct:  c’ =.02 
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Figure 2: Conditional process analysis – depression models 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 BCI 
Path – depression LL UL 
Total effect  
(Threat appraisals to depression) 
.01 .05 
Direct effect 
(Threat appraisals to depression) 
-.003 .05 
Total indirect effect 
(Threat appraisals to cognitive fusion to depression) 
.01 .03 
Total model R2=.25, p<.01, f2=6.64 
 
Total effect 
(MoCA to depression) 
-.06 .03 
Direct effect 
(MoCA to depression) 
-.07 .01 
Total Indirect effect 
(MoCA to cognitive fusion to depression) 
-.01 .05 
Total model  R2=.27, p<.01, f2=5.75 
Threat appraisals 
Cognitive fusion 
Depression 
a =.86**  β =.01 
Total:   c =.03** 
Direct: c’ =.02 
MoCA 
Cognitive fusion 
Depression 
a =.65  β =.02** 
Total:   c =-.05 
Direct: c’ =-.03 
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Figure 3: Conditional process analysis – quality of life models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Numbers on the path indicate unstandardised β coefficients. 
BCI: bootstrapped confidence interval; LL: Lower limit; UL: Upper limit 
*=significant at <0.05 level; **=significant at <0.01 level; ***=significant at <0.001 level  
 
 
 
 
 BCI 
Path – quality of life (QoL) LL UL 
Total effect  
(Threat appraisals to QoL) 
-.99 -.33 
Direct effect 
(Threat appraisals to QoL) 
-.90 -.15 
Total indirect effect 
(Threat appraisals to cognitive fusion to QoL) 
-.32 .06 
Total model R2=.39, p<.001, 
f2=9.80 
 
Total effect 
(MoCA to QoL) 
-1.1 .45 
Direct effect 
(MoCA to QoL) 
-.80 .59 
Total Indirect effect 
(MoCA to cognitive fusion to QoL) 
-.64 .15 
Total model  R2=.23, p<.05, 
f2=4.61 
Threat appraisals 
Cognitive fusion 
Quality of life 
a =.86**  β =-.16 
Total:   c =-.66***  
Direct: c’ =-.52** 
MoCA 
Cognitive fusion 
Quality of life 
a =.65  β =-.31** 
Total:  c  =-.31 
Direct: c’ =-.11 
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